Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ONCOTHYREON Inc ONTY

"Oncothyreon Inc is a clinical-stage biopharmaceutical company. It develops and commercializes synthetic vaccines & small molecules that treat the lives & outcomes of cancer patients."

NDAQ:ONTY - Post Discussion

ONCOTHYREON Inc > Nice timing..
View:
Post by Traderdan$$$ on Sep 24, 2010 10:00am

Nice timing..

the managemnet of this co should be shot....idiots. I hope they enjoy spending that cash. oh well it gives us long term suckers ...i mean investors an extra 12 months to live. so we are now good for about another 2 years unless they give themselves a big pay increase. Nice job. Just when the price was back to the level it was before the bombshell about the cancelation of the stimuvax trials. Perfect timing and a great price...3.50$ NICE !!! It was trading at 4.50 -4.75 Great job management. IDIOTS...if they had waited a couple of weeks they could have got a better deal. Not that anyone cares on this board but it felt good to vent.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities